Name: | Recombinant full length human α-synuclein |
HGNC Name: | SNCA |
RRID: | NA |
Format: | 1mg/mL in 6M Urea |
Applications: | Elisa and gel standard, immunogen |
Storage: | Stable at 4°C for one year, for longer term store at -20°C |
Uniprot: | P37840 |
Human α-Synuclein Protein,
Cat# Prot-r-SNCA
$300.00 – $2,000.00
α-synuclein is a member of the synuclein protein family, the other two members being β and γ-synuclein, each protein is coded for by a distinct but related gene. α-synuclein was originally isolated as a major synaptic vesicle associated protein from the electric organ of the fish Torpedo (1), and direct homologues of α-synuclein are found in all vertebrates. Later work connected α-synuclein expression with several human brain pathologies, it is a major component of the Lewy bodies of Parkinson’s disease (2). Point mutations of α-synuclein proved to be causative of some forms of familial Parkinson’s disease (3-5). One genetic cause of early onset Parkinson’s disease is duplication or triplication of one of the α-synuclein genes leading to excess production of the protein (6,7). α-synuclein is also found in the Lewy bodies of patients with diffuse Lewy body disease and inclusions in glial cells in the brains of patients with multiple system atrophy and amyotrophic lateral sclerosis. α-synuclein is normally heavily expressed in brain and appears to be localized primarily to presynaptic regions, though not with a typical synaptic vesicle distribution pattern.
A codon optimized cDNA encoding full length human α-synuclein was designed and inserted into the pET30a (+) expression vector. The vector adds an N-terminal His-tag to the human sequence which increases the molecular weight by about 5kDa. The construct was expressed by standard methods in E. coli and purified using a Nickel column in 6M urea. The protein is supplied in 6M urea in phosphate buffer. The lane on the far left contains protein standards of the indicated molecular size. In the next lanes 2µg, 1µg and 0.5µg of the recombinant α-synuclein were run as indicated and 1µg and 0.5µg of BSA were in the two right lanes.
Human α-synuclein sequence was based on that was NP_000336.1 which was inserted into the eukaryotic expression vector pET30a(+) which adds an N-terminal His-tag and some other sequence, underlined below. This sequence includes a thrombin cleavage site (blue), an S-tag affinity peptide (red) and an enterokinase cleavage site (green).
MHHHHHHSSG LVPRGSGMKE TAAAKFERQH MDSPDLGTDD DDKAMADIGS EFMDVFMKGL 60
SKAKEGVVAA AEKTKQGVAE AAGKTKEGVL YVGSKTKEGV VHGVATVAEK TKEQVTNVGG 120
AVVTGVTAVA QKTVEGAGSI AAATGFVKKD QLGKNEEGAP QEGILEDMPV DPDNEAYEMP 180
SEEGYQDYEP EA 192
Number of amino acids: 192
Molecular weight: 20168.36
Theoretical pI: 4.94
Amino acid composition:
Ala (A) 24 12.5%
Arg (R) 2 1.0%
Asn (N) 3 1.6%
Asp (D) 13 6.8%
Cys (C) 0 0.0%
Gln (Q) 7 3.6%
Glu (E) 21 10.9%
Gly (G) 23 12.0%
His (H) 8 4.2%
Ile (I) 3 1.6%
Leu (L) 6 3.1%
Lys (K) 18 9.4%
Met (M) 8 4.2%
Phe (F) 4 2.1%
Pro (P) 7 3.6%
Ser (S) 9 4.7%
Thr (T) 12 6.2%
Trp (W) 0 0.0%
Tyr (Y) 4 2.1%
Val (V) 20 10.4%
Extinction coefficients:
This protein does not contain any Trp residues. Experience shows that
this could result in more than 10% error in the computed extinction coefficient.
Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water.
Ext. coefficient 5960
Abs 0.1% (=1 g/l) 0.296
1. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8:2804-15 (1988).
2. Lavedan C. The Synuclein Family. Genome Research 8:871-80 (1998).
3. Polymeropoulos, MH et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045-7 (1997).
4. Kruger, R et al. Ala30-to-Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nature Genet. 18:106-8 (1998).
5. Chartier-Harlin, M-C. et al. Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364:1167-9 (2004).
6. Singleton, AB.et al. Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302:841 (2003).
7. Ibanez, P. et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson’s disease. Lancet 364:1169-71 (2004).
Related products
-
Recombinant ACE2 SARS-CoV2 Binding Domain
$300.00 – $2,000.00Select options This product has multiple variants. The options may be chosen on the product page -
Recombinant Human Vimentin
$300.00 – $2,000.00
Cat# Prot-r-VimSelect options This product has multiple variants. The options may be chosen on the product page -
Recombinant Human Peripherin
$300.00 – $2,000.00
Cat# Prot-r-PeriSelect options This product has multiple variants. The options may be chosen on the product page -
Recombinant Human UCHL1 Protein
$300.00 – $2,000.00
Cat# Prot-r-UCHL1Select options This product has multiple variants. The options may be chosen on the product page
Contact info
EnCor Biotechnology Inc.
4949 SW 41st Boulevard, Ste 40
Gainesville
Florida 32608 USA
Phone: (352) 372 7022
Fax: (352) 372 7066
E-mail: admin@encorbio.com